Medicus Pharma Ltd [NASDAQ: MDCX] stock went on an upward path that rose over 0.39% on previous day amounting to a one-week price decrease of less than -3.37%.
The one-year Medicus Pharma Ltd stock forecast points to a potential upside of 86.88. The average equity rating for MDCX stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $40.85 million, with 13.42 million shares outstanding and 2.34 million shares in the current float. Compared to the average trading volume of 205.67K shares, MDCX stock reached a trading volume of 120648 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Medicus Pharma Ltd [MDCX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MDCX shares is $19.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MDCX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Medicus Pharma Ltd is set at 0.58 The Price to Book ratio for the last quarter was 16.12, with the Price to Cash per share for the same quarter was set at 0.25.
MDCX Stock Performance Analysis:
Medicus Pharma Ltd [MDCX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.37. With this latest performance, MDCX shares dropped by -66.84% in over the last four-week period, additionally sinking by -6.18% over the last 6 months.
Insight into Medicus Pharma Ltd Fundamentals:
Return on Equity for this stock declined to -435.53%, with Return on Assets sitting at -435.53%.
MDCX Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MDCX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Medicus Pharma Ltd go to 5.68%.
Medicus Pharma Ltd [MDCX] Institutonal Ownership Details
There are presently around $19.20%, or 34.88%% of MDCX stock, in the hands of institutional investors.
